Study guide
13.2 Ethics, Confidentiality & Generic Substitution
DHA Pharmacist Licensing Assessment PHO5481
Track your progress as you read
Finished sections get a check mark.
1 Exam Overview & Licensing Pathway
1.1 Current Exam Facts & Format 1.2 Eligibility, PQR & the Sheryan Application Process 1.3 Study Strategy & Test-Day Plan
2 Cardiovascular Pharmacology
2.1 Antihypertensives & RAAS Agents 2.2 Heart Failure & Antiarrhythmic Drugs 2.3 Lipid-Lowering & Antianginal Agents
3 Endocrine & Metabolic Pharmacology
3.1 Insulin & Oral Antidiabetic Agents 3.2 Thyroid, Bone & Calcium Agents 3.3 Corticosteroids & Other Hormonal Agents
4 Anti-Infective Pharmacology
4.1 Beta-Lactam Antibiotics 4.2 Non-Beta-Lactam Antibacterials 4.3 Antifungals, Antivirals & Antituberculars
5 CNS, Psychiatric & Pain Pharmacology
5.1 Psychiatric Pharmacology 5.2 Antiepileptics & Neurologic Agents 5.3 Analgesics: NSAIDs, Opioids & Migraine
6 Respiratory, GI & Hematology Pharmacology
6.1 Respiratory Pharmacology 6.2 Gastrointestinal Pharmacology 6.3 Anticoagulants, Antiplatelets & Hematology Agents
7 Pharmaceutical Care: Cardiometabolic Disease
7.1 Diabetes Management & Counseling 7.2 Hypertension & Dyslipidemia Management 7.3 Heart Failure & Anticoagulation Management
8 Pharmaceutical Care: Respiratory, Rheumatology & Infection
8.1 Asthma & COPD Management 8.2 Gout, Pain & Rheumatologic Care 8.3 Infection Management & Antimicrobial Stewardship
9 Counseling, Monitoring & Special Populations
9.1 Patient Counseling, Adherence & Health Literacy 9.2 Therapeutic Monitoring & Laboratory Interpretation 9.3 Pregnancy, Pediatrics, Geriatrics & Organ Impairment 9.4 Pharmacoeconomics & Formulary Decision Making
10 Pharmaceutical Calculations I
10.1 Concentration, Ratio & Percentage Strength 10.2 Weight-Based & BSA Dosing 10.3 Dilution, Concentration & Alligation
11 Pharmaceutical Calculations II
11.1 Infusion Rates & IV Flow Calculations 11.2 Dispensing Quantities & Days' Supply 11.3 Compounding Calculations, Isotonicity & Milliequivalents
12 UAE Pharmacy Law & Regulation
12.1 UAE Regulatory Framework & Licensing Authorities 12.2 Medicine Registration, Pricing & Supply Chain 12.3 Prescription Requirements & Validity
13 Controlled Drugs, Ethics & Pharmacovigilance
13.1 Controlled & Semi-Controlled Medicines in the UAE 13.2 Ethics, Confidentiality & Generic Substitution 13.3 Pharmacovigilance, Recall & Medicine Disposal
14 Pharmacokinetics I: ADME
14.1 Absorption & Bioavailability 14.2 Distribution & Protein Binding 14.3 Metabolism & Elimination
15 Pharmacokinetics II: Kinetics, Dosing & TDM
15.1 Half-Life, Clearance & Kinetic Order 15.2 Loading & Maintenance Dosing 15.3 Therapeutic Drug Monitoring
16 OTC Medicines & Self-Care
16.1 Cough, Cold & Allergic Rhinitis 16.2 GI Self-Care: Heartburn, Constipation & Diarrhoea 16.3 Pain & Fever Self-Care 16.4 Referral Red Flags, Emergency Contraception & Skin
17 Medication Safety
17.1 High-Alert Medications & Error-Prone Abbreviations 17.2 Medication Reconciliation & Duplicate Therapy 17.3 Adverse Drug Reactions & Hypersensitivity Recognition
18 Sterile & Nonsterile Compounding
18.1 Aseptic Technique & Compounding Environments 18.2 Parenteral, TPN & Cytotoxic Preparation 18.3 Nonsterile Compounding
19 Pharmaceutics, Biopharmaceutics & Toxicology
19.1 Dosage Form Design & the Biopharmaceutics Classification System 19.2 Dissolution & Excipients 19.3 Toxicology: Poisoning Recognition & Antidotes
20 Infection Control, Natural Products, Medicinal Chemistry & Pharmacogenomics
20.1 Infection Control & Immunization 20.2 Pharmacognosy & Dietary Supplements 20.3 Medicinal Chemistry Essentials 20.4 Clinical Pharmacogenomics
13.2 Ethics, Confidentiality & Generic Substitution
Key Takeaways Explain This Topic AI
The four ethical pillars — autonomy, beneficence, non-maleficence and justice — map directly onto everyday dispensing decisions
Patient confidentiality may be breached only for serious-harm prevention or legal compulsion, and even then disclosure is limited to what is necessary
Direct-to-consumer advertising of prescription-only medicines is prohibited in the UAE, and industry gifts or incentives create declarable conflicts of interest
Generic substitution relies on bioequivalence; caution applies to narrow-therapeutic-index drugs such as levothyroxine, phenytoin, warfarin and ciclosporin
Therapeutic substitution (a different drug in the same class) is not generic substitution and requires prescriber agreement
Last updated: August 2026
The Four Pillars in Pharmacy Practice
Pharmacy ethics questions on the DHA exam are usually scenario-based applications of the four classical principles:
Autonomy — respecting the patient's right to informed choice. In practice: explaining options honestly, honouring a competent patient's refusal, and not concealing an error because disclosure is uncomfortable.
Beneficence — acting for the patient's benefit. In practice: proactively identifying interactions, counselling on adherence, referring red-flag symptoms rather than simply selling a product.
Non-maleficence — first, do no harm. In practice: refusing to dispense an unsafe or forged prescription even under pressure, checking allergy history, declining to supply antibiotics without a valid prescription.
Justice — fair treatment and fair allocation. In practice: not prioritising wealthier or pushier customers, applying substitution and pricing rules consistently, and equitable access during shortages.
Exam questions rarely ask for definitions alone; they present a dilemma — for example, a relative demanding information, or a profitable but inappropriate sale — and expect you to pick the option balancing autonomy and confidentiality against genuine harm risk.
Confidentiality and Health-Data Duties
A pharmacist holds health information in confidence as a legal and professional duty , not merely a courtesy. Prescription details, diagnoses inferred from medicines, and even the fact that someone is a patient are protected. Practical rules:
Family and employer inquiries. Do not disclose a patient's medicines or conditions to spouses, relatives, employers or insurers without the patient's explicit consent — however well-meaning the request. For children and patients lacking capacity, disclosure is to the legal guardian and limited to what care requires.
Exceptions. Confidentiality may be overridden only in narrow circumstances: to prevent serious harm to the patient or others, or under legal compulsion (a court order or a specific statutory duty to report). Even then, disclose the minimum necessary to the proper authority , and document the decision and its rationale.
Data handling. Health data must be stored securely, access-restricted, and never posted to social media or discussed in public areas. De-identified teaching use still demands genuine anonymisation.
Informed consent in pharmacy means the patient understands, in language they comprehend, what a medicine is for, how to take it and the material risks before agreeing — consent is a process of communication, not a signature.
Conflicts of Interest, Advertising and Professional Boundaries
Conflicts of interest arise when commercial gain could distort professional judgement — gifts, hospitality or incentive schemes from manufacturers that reward dispensing particular brands. The ethical rule is to avoid, declare and never allow inducements to influence clinical decisions ; substitution and recommendation decisions must rest on evidence, regulation and patient need.
Advertising. UAE rules prohibit direct-to-consumer advertising of prescription-only medicines (POM) ; promotion of POMs is confined to healthcare professionals through regulated channels, while over-the-counter products may be advertised within approved content rules. A pharmacist who promotes a POM brand to the public for a supplier's reward breaches both advertising and conflict-of-interest standards.
Conscientious objection has boundaries: a pharmacist with a genuine moral objection to supplying a lawful product should ensure the patient is referred promptly to another pharmacist or pharmacy so lawful care is not obstructed — objection protects the practitioner's conscience, it does not license obstruction or judgement of the patient.
Fitness to practise is a collective duty. A colleague practising while impaired — through substance misuse, untreated illness or conduct that endangers patients — should be supported toward help, but where patient safety is at risk there is a duty to report to the employer and, where necessary, the licensing authority. Protecting patients outranks protecting a colleague's reputation.
Generic Substitution
Generic substitution means dispensing a different manufacturer's product containing the same active ingredient, strength and dosage form in place of the prescribed brand. Its legal and scientific basis is bioequivalence : a registered generic must demonstrate that its rate and extent of absorption fall within the accepted equivalence limits of the reference product (conventionally, the 90% confidence interval for key pharmacokinetic measures lies within 80–125%). Because registered generics meet this standard, substitution is permitted — and often encouraged by payers — unless an exception applies:
The prescriber has explicitly marked no substitution or brand-necessary dispensing.
The medicine is a narrow-therapeutic-index (NTI) or critical-dose drug where small exposure shifts matter — classic examples are levothyroxine, phenytoin, warfarin and ciclosporin . Many authorities and guidelines advise keeping patients on a consistent product for these, and any enforced switch warrants monitoring.
No registered, bioequivalent generic exists for that product in the UAE market.
When a switch is made, the pharmacist should inform the patient , explain that appearance may differ while the active ingredient is unchanged, record the product dispensed, and counsel the patient to report any change in effect or new adverse effects — this documentation protects continuity if a problem later surfaces.
Generic vs therapeutic substitution
- Generic substitution Therapeutic substitution
- Active ingredient Same Different drug, same pharmacological class
- Scientific basis Bioequivalence Comparable class effect
Typical authority Pharmacist may do under regulation, unless barred Requires prescriber agreement — not a pharmacist's unilateral decision
Example Brand atorvastatin → registered generic atorvastatin Atorvastatin → rosuvastatin
Confusing these two is a classic exam trap: swapping omeprazole for esomeprazole, or one ACE inhibitor for another, is therapeutic substitution and needs the prescriber's authorisation, however reasonable it seems clinically.